menu
    • menu

    Company profile for The Global Health Innovative Technology

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The Japan-based GHIT Fund is an international public-private partnership fund for global health R&D that mobilizes Japanese industry, academia, and research institutes to create new drugs, vaccines, and diagnostics for malaria, tuberculosis, and neglected tropical diseases, in collaboration with global partners.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Global Health Innovative Technologyjapan Flag
    Country
    Country
    Japan
    Address
    Address
    Ark Hills Sengokuyama Mori Tower 25F, 1-9-10 Roppongi, Minato-ku, Tokyo, 106-0...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ghitfund.org/en
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project
    Eisai Invests $8.8M In Malaria, Tuberculosis, And NTD R&D Project

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/total-investment-of-approx-usd-8-8-million-in-malaria-tuberculosis-and-ntd-rd-projects-with-partners-including-mahidol-university-barcelona-institute-for-global-health-and-eisai-302675840.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    NIPRO, TBA, Japan Institute Invest $460K In Mpox Detection Test
    NIPRO, TBA, Japan Institute Invest $460K In Mpox Detection Test

    08 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/investment-of-approx-usd-460-000-for-the-development-of-a-prototype-mpox-detection-test-with-nipro-tba-japan-institute-for-health-security-and-others-302634409.html

    PR NEWSWIRE
    08 Dec 2025
    Share Share
    12.7M Invested In NTDs, Malaria Diagnostics, Drug Development
    12.7M Invested In NTDs, Malaria Diagnostics, Drug Development

    29 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/a-total-of-usd-12-7-million-investment-in-new-diagnostics-and-drug-development-for-ntds-and-malaria-to-partners-including-the-ohio-state-university-path-gsk-and-others-302363840.html

    PR NEWSWIRE
    29 Jan 2025
    Share Share
    GHIT Invests USD 4M in NTD Diagnostics, First Trachoma Investment
    GHIT Invests USD 4M in NTD Diagnostics, First Trachoma Investment

    06 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/approx-usd-4-0-m-invested-in-product-development-for-ntds---ghits-first-investment-in-the-development-of-diagnostics-for-trachoma-302298127.html

    PR NEWSWIRE
    06 Nov 2024
    Share Share
    GHIT Fund invests Y1.54bn in malaria and NTD drug projects
    GHIT Fund invests Y1.54bn in malaria and NTD drug projects

    09 May 2024

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/ghit-fund-malaria-ntd-drug-development/

    PHARMACEUTICAL TECHNOLOGY
    09 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search